Strata Critical Medical’s Public and Private Warrants Expire at 5 PM ET
Strata Critical Medical’s Public Warrants and Private Placement Warrants expired as scheduled at 5:00 PM Eastern Time on May 7, 2026, removing further potential share dilution under their original terms. The lapse of these instruments ends any prospect of exercise proceeds, leaving Strata’s capital structure unchanged beyond existing equity.
1. Expiration Details
Strata Critical Medical announced that both its Public Warrants (Nasdaq: SRTAW) and its Private Placement Warrants expired at 5:00 PM Eastern Time on May 7, 2026, in accordance with their original terms and without extension or exercise. No further warrant conversions will occur, closing the window for holders to subscribe to shares.
2. Capital Structure Impact
The lapse of these warrants eliminates the prospect of additional share issuance and removes related dilution from Strata’s equity base, while also foregoing any exercise-related cash inflows that could have bolstered the balance sheet. Existing shareholders will retain their proportional ownership until any new equity issuances.
3. Company Operations Overview
Strata is a time-critical logistics and medical services provider operating one of the nation’s largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, delivering integrated donor organ recovery solutions and perfusion staffing under its Trinity Medical Solutions and Keystone Perfusion brands.